CLINICAL RESPONSE OF SOFOSBUVIR (GENERIC, SEARLE) BASED TREATMENT OF CHRONIC HEPATITIS C INFECTION: A PAKISTANI REAL LIFE STUDY HOME (HEPATITIS OBSERVATIONAL MANAGEMENT ENVISION)

Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2018, Vol 5, Issue 1

Abstract

Background: Globally, Interferon-free direct-acting antiviral therapy has revolutionized treatment for Chronic Hepatitis C (HCV). However, due to the slow regulatory process of DAAs registration in Pakistan and differ the current AASLD/IDSA Hepatitis C guidance, the Sofosbuvir/Ribavirin combination is the registered treatment therapy. Objective: This Post-Marketing Observational Studies (PMOS) conducted across 30 sites at 10 major cities of Pakistan, evaluating the safety and efficacy of Sofosbuvir (Searle, Pakistan) plus Ribavirin (generic, Searle, Pakistan) therapy among treatment-naïve Pakistani patients with chronic genotype 3 HCV infection. Methods: In the HOME (Hepatitis Observational Management Envision) study as per study inclusion/exclusion criteria, 244 GT-3 HCV infected naïve Pakistani patients, non-cirrhotic received SOF (generic) 400mg with Ribavirin (generic, Searle) daily for 24 weeks. The study assess the overall safety, virological response at week 4 and Sustained Virological Response at week 12 (SVR). Results: Out of 244 patients, 121 (49.59%) females while 123 (50.40%) were males with Mean age of 43.16±11.21 (S.D). The HCV RNA become negative in 231 (94.6%) patients at week 4 of treatment. Headaches and fatigue were the most common reported adverse events with no serious adverse event reported. Conclusion: The week 4 study interim analysis response indicates the probability of achieving SVR12 in the heterogeneous group (demographics distribution) across Pakistan with Sofosbuvir Ribavirin (Generic, Searle) regimen therapy in HCV genotype 3-infected individuals without cirrhosis. With the promising week 4 results, the better outcomes are expected in the final SVR results of the study. Overall, the regimen of SOF/RIB (Generic, Searle) for 4 weeks therapy also observed to be safe and well tolerated.

Authors and Affiliations

Dr. Ali Yasir

Keywords

Related Articles

BIOACCUMULATION OF LEAD IN TISSUES OF PASSER DOMESTICUS AS A BIOINDICATOR SPECIES IN BIRJAND

Recently development of human lifestyle and urbanization have resulted in elevated levels of different contaminants in our environment. Heavy metals specially lead (Pb) is a main issue worldwide, regional and local level...

NEUROPROTECTIVE AND ANTITOXIC POTENTIAL OF HYDROMETHANOLIC EXTRACT OF ALLIUM CEPA IN EXPERIMENTAL RATS

This research studied the neuroprotective potential of Allium cepa hydromethanolic extract on neurotoxicity due to lead acetate treatment. 30 male wistar rats were used. The animals were grouped simple randomly into 6 se...

CLİNİCAL DİAGNOSİS AND TREATMENT OF ACUTE BACTERİAL MENİNGİTİS: A COMPREHENSİVE LİTERATURE REVİEW

Acute bacterial meningitis (ABM) is still a substantial cause of high mortality and severe neurological morbidity during recent decades, despite the advances in diagnosis and antimicrobial therapy.Streptococcus pneumonia...

SIMULTANEOUS SPECTROPHOTOMETRIC DETERMINATION OF PARACETAMOL AND CODEINE

A novel, accurate, and simple UV – spectrophotometric method for simultaneous determination of paracetamol (PCM) and codeine (COD) in mixture of standard and tablets formulation was verification in this work without any...

MALARIA IN PREGNANCY A COMPARATIVE STUDY OF PREGNANT WOMEN IN TWO HOSPITALS

The prevalence of malaria among pregnant women was determined in Braithwaite Memorial Specialist Hospital (BMSH) and Bori General Hospital (BGH) by direct examination of stained blood smear using Giemsa method. A total o...

Download PDF file
  • EP ID EP635068
  • DOI -
  • Views 167
  • Downloads 0

How To Cite

Dr. Ali Yasir (2018). CLINICAL RESPONSE OF SOFOSBUVIR (GENERIC, SEARLE) BASED TREATMENT OF CHRONIC HEPATITIS C INFECTION: A PAKISTANI REAL LIFE STUDY HOME (HEPATITIS OBSERVATIONAL MANAGEMENT ENVISION). European Journal of Pharmaceutical and Medical Research, 5(1), 104-107. https://www.europub.co.uk/articles/-A-635068